Ansaripour6

Dr Amir Ansaripour

Dr Amir Ansaripour (Ph.D.) is a health economist. He has collaborated with pharma companies from different countries in cost-effectiveness analyses of new technologies for various diseases.
His Ph.D. research focused on cost-effectiveness analyses, modeling, and reimbursement policy analysis. During past years, he has applied various methods such as questionnaire/survey analysis, data mining on a large claims database, real-world cost analysis, Markov modeling, pharmaceutical pricing, and market access strategy in his projects.